5345-57-3Relevant articles and documents
COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS
-
Page/Page column 279, (2019/04/26)
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
4-(1-AMINO-ETHYL)-CYCLOHEXYLAMINE DERIVATIVES
-
Page/Page column 37, (2010/03/02)
The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2 /su